Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Volume 59, Issue 1, Pages (July 2013)

The impact of hepatitis E in the liver transplant setting

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Volume 67, Issue 2, Pages (August 2017)

Volume 42, Issue 6, Pages (June 2005)

Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 65, Issue 4, Pages (October 2016)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 42, Issue 1, Pages (January 2005)

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

Volume 68, Issue 3, Pages (March 2018)

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B W.-K. Seto, D. K.-H. Wong,

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Ming-Ling Chang, Yun-Fan Liaw Journal of Hepatology

Volume 68, Issue 4, Pages (April 2018)

Autophagy in the liver Journal of Hepatology

EASL Clinical Practice Guidelines: Wilson’s disease

Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok

Volume 42, Issue 4, Pages (April 2005)

Volume 42, Issue 3, Pages (March 2005)

Volume 50, Issue 4, Pages (April 2009)

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Volume 50, Issue 3, Pages (March 2009)

Immigration and viral hepatitis

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

The impact of intestinal microflora on serum bilirubin levels

Volume 64, Issue 6, Pages (June 2016)

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Serum HBV pgRNA as a clinical marker for cccDNA activity

Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection Isabelle Chemin,

Volume 51, Issue 2, Pages (August 2009)

The use of hemospray in portal hypertensive bleeding; a case series

Chronic hepatitis B in children and adolescents

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing Roongruedee Chaiteerakij,

Chimeric mouse model of hepatitis B virus infection

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Volume 60, Issue 5, Pages (May 2014)

MELD: the holy grail of organ allocation?

Volume 65, Issue 4, Pages (October 2016)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients D. He, S. Guo, P. Zhu, S. Tao, M. Li,

Presentation transcript:

Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity” Jie Wang, Man Du, Hongxin Huang, Ran Chen, Junqi Niu, Jianning Jiang, Hui Zhuang, Fengmin Lu Journal of Hepatology Volume 66, Issue 2, Pages 462-463 (February 2017) DOI: 10.1016/j.jhep.2016.10.034 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Serum HBV RNA correlations with intrahepatic cccDNA in HBeAg-positive and negative patients. (A) Analysis of the correlation between serum HBV RNA and intrahepatic cccDNA in HBeAg-positive patients and (B) HBeAg-negative patients with chronic HBV infection. Journal of Hepatology 2017 66, 462-463DOI: (10.1016/j.jhep.2016.10.034) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions